During the past decade, Dilek alemdar conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Dilek alemdar" are "COVID-19" (1 trials), "Emotional Eating" (1 trials), "Metabolic Syndrome" (1 trials) and "Stress, Psychological" (1 trials). Many other conditions were trialed in "Dilek alemdar" in a lesser frequency.

Most popular intervention types in "Dilek alemdar" are "Behavioral" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "A survey form was applied to individuals included in the study face-to-face." (1 trials) and "Supportive interventions on the stress levels of mothers of infants hospitalized in the Neonatal Intensive Care Unit (NICU)." (1 trials). Other intervention names were less common.

The vast majority of trials in "Dilek alemdar" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Dilek alemdar". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Dilek alemdar, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Dilek alemdar, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".